NCT02417233

Brief Summary

This study will evaluate the efficacy of two strategies for enhancing overall preventive behaviors, retention in HIV care, and adherence to medication for HIV positive individuals in South Africa: short message service (SMS) text messaging and peer navigation services.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
756

participants targeted

Target at P75+ for not_applicable hiv

Timeline
Completed

Started Oct 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 12, 2014

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 15, 2015

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
2.2 years until next milestone

Results Posted

Study results publicly available

August 20, 2018

Completed
Last Updated

August 20, 2018

Status Verified

November 1, 2017

Enrollment Period

1.7 years

First QC Date

December 12, 2014

Results QC Date

June 27, 2017

Last Update Submit

November 17, 2017

Conditions

Keywords

HIV-positiveadherenceengagement to caremobile Health (mHealth)SMSpeer navigationretention

Outcome Measures

Primary Outcomes (6)

  • Linkage to Care - Participants Who Received Cluster of Differentiation 4 (CD4) T-cell Count Test Result Within 3 Months of Testing HIV-positive (Binary)

    Participants who received CD4 count test result within 3 months of testing HIV-positive (binary)

    3 months

  • Timely Antiretroviral Therapy (ART) Initiation (Participants Eligible for ART Who Initiate Treatment Within 3 Months of Diagnosis)

    Participants eligible for ART who initiate treatment within 3 months of diagnosis

    3 months

  • Retention in Care - ART Eligible (Participants Eligible for ART Who Initiated ART and Who Remain on Treatment)

    Participants eligible for ART who initiated ART and who remain on treatment 12 months from enrollment. Retention in care at 12 months is defined as at least 4 clinical care visits with less than 4 months between each visit.

    12 months

  • Retention in Care - Non-ART (Participants Who Return for Repeat CD4 Testing Within 12 Months of Diagnosis)

    Participants who return for repeat CD4 testing within 12 months of diagnosis

    12 months

  • Adherence to ART - Objective (Viral Load Test Results <400 Copies/mL)

    Viral load test results \<400 copies/mL (consistent with current and correct adherence to ART)

    12 months

  • Adherence to ART - Subjective (Self-reported Ability to Take ART as Prescribed in Last Month)

    Self-reported ability to take ART as prescribed in last month, assessed at 12 months from enrollment. Considered compliant if reported "very good" or "excellent" adherence.

    12 months

Study Arms (3)

Standard of Care

NO INTERVENTION

Participants are administered baseline, 6 month, and 12 month questionnaires and provided with the study incentive (mobile phone airtime) only. This group will not receive any additional engagement to care intervention.

SMS text message

ACTIVE COMPARATOR

Participants are administered baseline, 6 month, and 12 month questionnaires and provided with the study incentive (mobile phone airtime). In addition, they receive automated bi-weekly behavioral text messages aimed at improving health and reducing transmission risk and also automated bi-weekly "check-in" text messages that will trigger a phone call from clinic staff if the participant reports not being well.

Behavioral: SMS text message

SMS text message + Peer Navigation

ACTIVE COMPARATOR

Participants are administered baseline, 6 month, and 12 month questionnaires and provided with the study incentive (mobile phone airtime). In addition, they receive automated bi-weekly behavioral text messages aimed at improving health and reducing transmission risk and also bi-weekly contact from an HIV-positive peer who provides personalized support and with health or other service systems navigation assistance.

Behavioral: SMS text message + Peer Navigation

Interventions

bi-weekly behavioral messages and bi-weekly check-in messages

SMS text message

bi-weekly behavioral messages plus personalized peer navigation

SMS text message + Peer Navigation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV positive (diagnosed within the last 12 months prior to study/patient contact)
  • Has access to a mobile phone
  • Willing to receive and respond to text messages and calls from clinic and study staff (all arms)
  • Willing to communicate and meet with PN (PN arm)
  • Willing to meet with study staff for survey at study start, 6 months, and 12 months (all arms)
  • regard study clinic area as the regular clinic for accessing healthcare

You may not qualify if:

  • First tested positive over 12 months prior to recruitment
  • Under the age of 18
  • Unable to give informed consent
  • Unable to read basic English and with no one to read study sms to participant
  • Principally accesses care through a clinic not in the study
  • Planning to permanently move away from the area served by the clinic within next 6 months (following enrollment)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Moses Kotane Sub-district clinics

Mabeskraal, Northwest, South Africa

Location

Rustenburg Sub-district clinics

Rustenburg, Northwest, South Africa

Location

Related Publications (5)

  • Leslie HH, Mooney AC, Gilmore HJ, Agnew E, Grignon JS, deKadt J, Shade SB, Ratlhagana MJ, Sumitani J, Barnhart S, Steward WT, Lippman SA. Prevalence, motivation, and outcomes of clinic transfer in a clinical cohort of people living with HIV in North West Province, South Africa. BMC Health Serv Res. 2022 Dec 26;22(1):1584. doi: 10.1186/s12913-022-08962-8.

  • Lippman SA, de Kadt J, Ratlhagana MJ, Agnew E, Gilmore H, Sumitani J, Grignon J, Gutin SA, Shade SB, Gilvydis JM, Tumbo J, Barnhart S, Steward WT. Impact of short message service and peer navigation on linkage to care and antiretroviral therapy initiation in South Africa. AIDS. 2023 Mar 15;37(4):647-657. doi: 10.1097/QAD.0000000000003453. Epub 2022 Dec 5.

  • Steward WT, Agnew E, de Kadt J, Ratlhagana MJ, Sumitani J, Gilmore HJ, Grignon J, Shade SB, Tumbo J, Barnhart S, Lippman SA. Impact of SMS and peer navigation on retention in HIV care among adults in South Africa: results of a three-arm cluster randomized controlled trial. J Int AIDS Soc. 2021 Aug;24(8):e25774. doi: 10.1002/jia2.25774.

  • Palmer MJ, Henschke N, Villanueva G, Maayan N, Bergman H, Glenton C, Lewin S, Fonhus MS, Tamrat T, Mehl GL, Free C. Targeted client communication via mobile devices for improving sexual and reproductive health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013680. doi: 10.1002/14651858.CD013680.

  • Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Trials. 2016 Feb 6;17:68. doi: 10.1186/s13063-016-1190-y.

MeSH Terms

Conditions

HIV Seropositivity

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Dr. Sheri Lippman
Organization
University of California San Francisco

Study Officials

  • Sheri Lippman, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2014

First Posted

April 15, 2015

Study Start

October 1, 2014

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

August 20, 2018

Results First Posted

August 20, 2018

Record last verified: 2017-11

Locations